Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy

Shamsi, Anas ; Mohammad, Taj ; Anwar, Saleha ; AlAjmi, Mohamed F ; Hussain, Afzal ; Rehman, Md Tabish ; Islam, Asimul ; Hassan, Md Imtaiyaz

Bioscience reports, 2020-06, Vol.40 (6), p.1 [Periódico revisado por pares]

England: Springer Nature B.V

Texto completo disponível